Crystal structure of the conserved hypothetical protein Rv1155 from Mycobacterium tuberculosis

With the aim of elucidating the biological function of hypothetical proteins unique amongst the Actynomyces sub‐group of bacteria, we have solved the crystal structure of the conserved hypothetical protein Rv1155 from Mycobacterium tuberculosis at 1.8 Å resolution. Rv1155 is a homodimer both in the crystal structure and in solution and folds into two separate domains consisting of a six‐stranded anti‐parallel β‐barrel fold flanked by two α‐helices and a helix‐turn‐helix domain. Both domains contribute to the formation of two deep clefts at the dimer interface. The overall fold of Rv1155 strikingly resembles that of flavin mononucleotide‐binding protein and pyridoxamine 5′‐phosphate oxydase, but the architecture of the putative binding pocket is markedly different, consistent with the lack of color of Rv1155 and its inability to bind FMN. Rv1155 thus appears to belong to a group of proteins with stringent conservation of the binding cleft, having evolved towards a new binding function.

[1]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[2]  S. Cole,et al.  Physical mapping of Mycobacterium bovis BCG pasteur reveals differences from the genome map of Mycobacterium tuberculosis H37Rv and from M. bovis. , 1996, Microbiology.

[3]  S. H. Kaufmann,et al.  Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens , 1999, Molecular microbiology.

[4]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[5]  R. Fairman,et al.  Biochemical Characterization of WrbA, Founding Member of a New Family of Multimeric Flavodoxin-like Proteins* , 1998, The Journal of Biological Chemistry.

[6]  R F Standaert,et al.  Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. , 1993, Journal of molecular biology.

[7]  B. Barrell,et al.  Use of a Mycobacterium tuberculosisH37Rv Bacterial Artificial Chromosome Library for Genome Mapping, Sequencing, and Comparative Genomics , 1998, Infection and Immunity.

[8]  Thomas C. Terwilliger,et al.  Electronic Reprint Biological Crystallography Maximum-likelihood Density Modification , 2022 .

[9]  Christopher Dye,et al.  Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country , 1999 .

[10]  L. Lally.  The CCP 4 Suite — Computer programs for protein crystallography , 1998 .

[11]  Ruedi Aebersold,et al.  Complementary Analysis of the Mycobacterium tuberculosis Proteome by Two-dimensional Electrophoresis and Isotope-coded Affinity Tag Technology * , 2004, Molecular & Cellular Proteomics.

[12]  K. M. Routzahn,et al.  Maltodextrin‐binding proteins from diverse bacteria and archaea are potent solubility enhancers , 2003, FEBS letters.

[13]  G. Otting,et al.  Pathway of chymotrypsin evolution suggested by the structure of the FMN-binding protein from Desulfovibrio vulgaris (Miyazaki F) , 1997, Nature Structural Biology.

[14]  T. Ko,et al.  Structure and properties of recombinant human pyridoxine 5′‐phosphate oxidase , 2003, Protein science : a publication of the Protein Society.

[15]  H. Edelsbrunner,et al.  Anatomy of protein pockets and cavities: Measurement of binding site geometry and implications for ligand design , 1998, Protein science : a publication of the Protein Society.

[16]  Claudine Médigue,et al.  Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. , 2002, Microbiology.

[17]  S. Withers,et al.  Crystal structure of Thermotoga maritima alpha-L-fucosidase. Insights into the catalytic mechanism and the molecular basis for fucosidosis. , 2004, The Journal of biological chemistry.

[18]  Anastassis Perrakis,et al.  Automated protein model building combined with iterative structure refinement , 1999, Nature Structural Biology.

[19]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[20]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[21]  Thomas C. Terwilliger,et al.  Automated MAD and MIR structure solution , 1999, Acta crystallographica. Section D, Biological crystallography.

[22]  C. Dye,et al.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.

[23]  D. Abraham,et al.  X-ray structure of Escherichia coli pyridoxine 5'-phosphate oxidase complexed with FMN at 1.8 A resolution. , 2000, Structure.

[24]  Renaud Vincentelli,et al.  A medium-throughput crystallization approach. , 2002, Acta crystallographica. Section D, Biological crystallography.

[25]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[26]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[27]  K. Terpe.  Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems , 2002, Applied Microbiology and Biotechnology.

[28]  Christopher M. Sassetti,et al.  Genetic requirements for mycobacterial survival during infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.